THERAPY FOR THE TREATMENT OF CANCER

The present invention is directed to regimens for administering one or more Antibody-Based Molecules that bind PD-1 or PD-L1, and LAG-3 (e.g, a PD-1×LAG-3 bispecific molecule) alone, or in combination with an Antibody-Based Molecule that binds a Tumor Antigen (TA) for the treatment of cancer. The in...

Full description

Saved in:
Bibliographic Details
Main Authors LA MOTTE-MOHS, Ross, WIGGINTON, Jon, Marc, BONVINI, Ezio, SUMROW, Bradley, James, MOORE, Paul, A, KOENIG, Scott, ZHANG, Xiaoyu
Format Patent
LanguageEnglish
French
German
Published 10.01.2024
Subjects
Online AccessGet full text

Cover

Loading…